
Cannabidiol reduces withdrawal symptoms in nicotine-dependent rats
Findings suggest CBD may be used as a strategy to alleviate the withdrawal symptoms upon nicotine cessation.
Findings suggest CBD may be used as a strategy to alleviate the withdrawal symptoms upon nicotine cessation.
In November 2020, the California Bureau of Cannabis Control (BCC) announced the recipients for its public university research grants program. The BCC received more than 100 applications from public universities across California. Research proposals had to fall within one of the several specified categories which included public health, criminal justice and public safety, economic, environmental impacts, and the cannabis industry. Below are the projects by UC San Diego researchers that received funding.
Principal Investigator | Research proposal title | Awarded funding |
Hill, Linda | The Public Health Impact of Cannabis Legalization in California: A Comprehensive Qualitative and Quantitative Analysis by Age, Gender, Race/Ethnicity, and Regions | $1,321,833 |
Shi, Yuyan | Evaluating the Impacts of Packaging and Labeling on Cannabis Edible Use among Youth | $987,738 |
Morgan, Erin | The Role of Cannabidiol in Anandamide-Related Improvement in Alexithymia and Health Outcomes | $887,101 |
Han, Benjamin | Evaluating Risks and Benefits of Cannabis Use by Older Adults: A Pilot | $235,039 |
Congratulations to UC San Diego cannabis researchers on the success of their applications!
John Watson, Medscape, January 5, 2021
Dr. Mark Wallace spoke to Medscape about cannabis treatment for pain management and other current cannabis research taking place at CMCR and UC San Diego.
Brooke Staggs, Orange County Register, March 19, 2021
The California Highway Patrol recently published its Impaired Driving Task Force report which gives recommendations on how to better track and test for drivers impaired by marijuana and other drugs. This article reviews some of the report's findings and recommendations.
The goal of the CMCR is to foster the careers of future generations of basic and clinical scientists who will help develop deeper understanding of the potentials of medical cannabis as well as the interactions of cannabis and cannabinoids on health and social and behavioral functioning. The Center addresses a broad range of areas in cannabinoid science, including the treatment of various medical and psychiatric conditions, pharmacology, animal models, and possible adverse effects (e.g., cognition, driving) of cannabis use. Details on the CMCR can be found at www.cmcr.ucsd.edu.
The scholar would work with CMCR leadership on projects advancing the mission of the Center and would be expected to ultimately develop his/her own grant submissions.
Previous research experience is desired. Selection criteria include the degree to which the applicant matches with the above-mentioned areas of interest.
Salary is based upon the NIH payscale and the candidate’s experience. Appointments are typically for one year with options to renew based on CMCR priorities and University policies.
Potential applicants who wish to learn more about the program may contact Dr. Tom Marcotte via email (
Page 14 of 22